4.6 Review

SHANK genes in autism: Defining therapeutic targets

Journal

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pnpbp.2017.11.019

Keywords

-

Funding

  1. Comitato Telethon Fondazione Onlus grant [GGP16131]

Ask authors/readers for more resources

The term Shankopathies identifies neurodevelopmental diseases, such as autism Spectrum Disorders (ASD), Intellectual Disability (ID), and schizophrenia (SCZ) caused by deletion or mutations of SHANK/ProSAP genes. The three SHANK genes code for a postsynaptic scaffold protein which has a main function of regulating synaptic formation, development and plasticity. The review summarizes the major genetic, molecular and electrophysiological studies that provide new information about the function of Shanks proteins and are prodromic in identifying therapeutic approaches, pharmacological targets for treating patients with SHANK deletions and mutations and eventually for other patients affected by neuropsychiatric and neurodevelopmental disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available